Literature DB >> 11407592

Integration of the pRB and p53 cell cycle control pathways.

C L Stewart1, A M Soria, P A Hamel.   

Abstract

Two fundamental molecular pathways, the pRB and p53 pathways, regulate cell growth and cell death. The importance of these pathways in cellular growth control is underscored by the observation that members of these pathways are found mutated in all human cancers. These two pathways have typically been studied and described independently. However, as we discuss here, recent data have revealed an intimate molecular and genetic interaction between the p53 and pRB pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407592     DOI: 10.1023/a:1010615822317

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  258 in total

Review 1.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

2.  E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2.

Authors:  T F Kowalik; J DeGregori; G Leone; L Jakoi; J R Nevins
Journal:  Cell Growth Differ       Date:  1998-02

3.  E1A transcription induction: enhanced binding of a factor to upstream promoter sequences.

Authors:  I Kovesdi; R Reichel; J R Nevins
Journal:  Science       Date:  1986-02-14       Impact factor: 47.728

4.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

5.  Induced differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression.

Authors:  N Y Rots; A Iavarone; V Bromleigh; L P Freedman
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

6.  Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53.

Authors:  W Tao; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

7.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

8.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

9.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

10.  Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein.

Authors:  K Martin; D Trouche; C Hagemeier; T S Sørensen; N B La Thangue; T Kouzarides
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

View more
  2 in total

1.  Immunohistochemical markers for prognosis of oligodendroglial neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Regina Sycheva
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

2.  P16 and p53 play distinct roles in different subtypes of breast cancer.

Authors:  Ming Shan; Xianyu Zhang; Xiaolong Liu; Yu Qin; Tong Liu; Yang Liu; Ji Wang; Zhenbin Zhong; Youxue Zhang; Jingshu Geng; Da Pang
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.